Jacob Crawshaw

Jacob Crawshaw

Auto-generated profile, based on publicly available information

Jacob Crawshaw

Affiliation Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Journal of Psychosomatic Research
Verified
Journal Article
Open access
JCJacob Crawshaw
Jacob Crawshaw
VAVivian Auyeung
Vivian Auyeung
SNSam Norton
Sam Norton
JWJohn Weinman
John Weinman
Medication non-adherence following acute coronary syndrome (ACS) is associated with poor clinical outcomes. A systematic review and meta-analysis were undertaken to identify psychosocial factors associated with medication adherence in patients with ACS. A search of electronic databases (Cochrane Library, Medline, EMBASE, PsycINFO, Web of Science, International Pharmaceutical Abstracts, CINAHL, ASSIA, OpenGrey, EthOS and WorldCat) was undertaken to identify relevant articles published in English between 2000 and 2014. Articles were screened against our inclusion criteria and data on study design, sample characteristics, predictors, outcomes, analyses, key findings and study limitations were abstracted. Our search identified 3609 records, of which 17 articles met our inclusion criteria (15 independent studies). Eight out of ten studies found an association between depression and non-adherence. A meta-analysis revealed that depressed patients were twice as likely to be non-adherent compared to patients without depression (OR=2.00, 95% CI 1.57-3.33, p=0.015). Type D personality was found to predict non-adherence in both studies in which it was measured. Three out of three studies reported that treatment beliefs based on the Necessity-Concerns Framework predicted medication non-adherence and there was some evidence that social support was associated with better adherence. There was insufficient data to meta-analyse all other psychosocial factors identified. There was some evidence that psychosocial factors, particularly depression, were associated with medication adherence following ACS. Targeting depressive symptoms, screening for Type D personality, challenging maladaptive treatment beliefs, and providing better social support for patients may be useful strategies to improve medication adherence.

14 June 2022 in Public Health
Verified
Journal Article
Closed access
JCJ. Crawshaw
J. Crawshaw
KKK. Konnyu
K. Konnyu
GCG. Castillo
G. Castillo
ZAZ. van Allen
Z. van Allen
JGJ.M. Grimshaw
J.M. Grimshaw
JPJ. Presseau
J. Presseau

21 November 2023 in Implementation Science
Verified
Journal Article
Open access
PDF file
JCJacob Crawshaw
Jacob Crawshaw
CMCarly Meyer
Carly Meyer
VAVivi Antonopoulou
Vivi Antonopoulou
JAJesmin Antony
Jesmin Antony
JGJeremy M. Grimshaw
Jeremy M. Grimshaw
FLFabiana Lorencatto
Fabiana Lorencatto
Background: Audit and feedback (A&F) is among the most widely used implementation strategies, providing healthcare professionals with summaries of their practice performance to prompt behaviour change and optimize care. Wide variability in effectiveness of A&F has spurred efforts to explore why some A&F interventions are more effective than others. Unpacking the variability of the content of A&F interventions in terms of their component behaviours change techniques (BCTs) may help advance our understanding of how A&F works best. This study aimed to systematically specify BCTs in A&F interventions targeting healthcare professional practice change. Methods: We conducted a directed content analysis of intervention descriptions in 287 randomized trials included in an ongoing Cochrane systematic review update of A&F interventions (searched up to June 2020). Three trained researchers identified and categorized BCTs in all trial arms (treatment & control/comparator) using the 93-item BCT Taxonomy version 1. The original BCT definitions and examples in the taxonomy were adapted to include A&F-specific decision rules and examples. Two additional BCTs (‘Education (unspecified)’ and ‘Feedback (unspecified)’) were added, such that 95 BCTs were considered for coding. Results: In total, 47/95 BCTs (49%) were identified across 360 treatment arms at least once (median = 5.0, IQR = 2.3, range = 1-29). The most common BCTs were ‘Feedback on behaviour’ (present 89% of the time; e.g. feedback on drug prescribing), ‘Instruction on how to perform the behaviour’ (71%; e.g. issuing a clinical guideline), ‘Social comparison’ (52%; e.g. feedback on performance of peers), ‘Credible source’ (41%; e.g. endorsements from respected professional body), and ‘Education (unspecified)’ (31%; e.g. giving a lecture to staff). A total of 130/287 (45%) control/comparator arms contained at least one BCT (median = 2.0, IQR = 3.0, range = 0–15 per arm), of which the most common were identical to those identified in treatment arms. Conclusions: A&F interventions to improve healthcare professional practice include a moderate range of BCTs, focusing predominantly on providing behavioural feedback, sharing guidelines, peer comparison data, education, and leveraging credible sources. We encourage the use of our A&F-specific list of BCTs to improve knowledge of what is being delivered in A&F interventions. Our study provides a basis for exploring which BCTs are associated with intervention effectiveness. Trial registrations: N/A.

20 February 2015 in Annals of Behavioral Medicine
Verified
Journal Article
Closed access
PDF file
JCJacob Crawshaw
Jacob Crawshaw
HRHelen Rimington
Helen Rimington
JWJohn Weinman
John Weinman
JCJoseph Chilcot
Joseph Chilcot
The aim of the present study was to examine whether profiles of illness perceptions are associated with 10-year survival following cardiac valve replacement surgery. Illness perceptions were evaluated in 204 cardiac patients awaiting first-time valve replacement and again 1 year post-operatively using cluster analysis. All-cause mortality was recorded over a 10-year period. At 1 year, 136 patients were grouped into one of four profiles (stable positive, stable negative, changed from positive to negative, changed from negative to positive). The median follow-up was 3063 days (78 deaths). After controlling for clinical covariates, including markers of function, patients who changed illness perceptions from positive to negative beliefs 1 year post-surgery had an increased mortality risk (hazard ratio (HR) = 3.2, 95 % confidence interval (CI) 1.2–8.3, p = .02) compared to patients who held positive stable perceptions. Following cardiac valve replacement, developing negative illness perceptions over the first post-operative year predicts long-term mortality. Early screening and intervention to alter this pattern of beliefs may be beneficial.

1 February 2018 in Thrombosis Research
Verified
Journal Article
Open access
JAJohn K. Bartoli- Abdou
John K. Bartoli- Abdou
JPJignesh P. Patel
Jignesh P. Patel
JCJacob Crawshaw
Jacob Crawshaw
BVBipin Vadher
Bipin Vadher
ABAlison Brown
Alison Brown
VAVivian Auyeung
Vivian Auyeung
Current UK and European guidelines recommend anticoagulated patients prescribed warfarin with time in therapeutic range (TTR) 1year previously were invited to participate in focus groups. Two focus groups for atrial fibrillation (AF) and two for secondary prevention of venous thromboembolism (VTE) patients were held at anticoagulation clinics in South London, UK. Data was analysed using framework analysis to extract dominant themes. Five VTE patients and 15 AF patients attended the focus groups. Dominant themes that emerged were: indication specific anticoagulation prioritisation, warfarin as a necessary inconvenience, DOACs as the anticoagulant of choice, concerns regarding DOAC monitoring, high adherence to DOACs and desire for long-term access to specialist anticoagulation services. VTE patients prioritised anticoagulation over other therapies whereas AF patients did not. All participants reported high levels of adherence to DOACs. Patients derived confidence from long-term management in specialist anticoagulation clinics stating a preference to be managed in such a service.

22 July 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
JCJacob Crawshaw
Jacob Crawshaw
NMNicola McCleary
Nicola McCleary
Medication adherence remains a global health issue and healthcare providers (HCPs) play an important role in supporting patients to adhere to treatment. This article provides a state-of-the-science overview of the evidence for: i) the effectiveness of HCP-delivered interventions on medication adherence outcomes; and ii) the types of implementation approaches targeting evidence-to-practice gaps among HCPs supporting medication adherence. Hundreds of randomized controlled trials and dozens of systematic reviews on the effectiveness of HCP-delivered interventions have been conducted to date. HCP-delivered interventions typically produce small-to-medium effect sizes on adherence outcomes, however, there is considerable heterogeneity in effects and few interventions that show promise are implemented into routine practice. Some key features of potentially effective HCP-delivered interventions include: moving beyond education-only, using multiple behaviour change strategies, tailoring interventions to different determinants of non-adherence, incorporating pharmacists and nurses to deliver interventions, providing ongoing support to patients, and addressing health system-level barriers and inequities. To improve the uptake of evidence into adherence-related clinical practice, it is likely that health systems must adapt to enable HCPs to better support adherence over time and in a patient-centered way. Such approaches include, improving routine screening of adherence issues, making adherence-related clinical guidelines more actionable, using routinely collected data to identify patients with adherence challenges, enhancing HCP incentivization models, and establishing quality indicators for adherence monitoring and support. Concepts and evidence from implementation science should be leveraged to support these types of system-level approaches to address evidence-to-practice gaps. In conclusion, despite an extensive evidence base for the effectiveness of HCP-delivered interventions - and a growing body of evidence for approaches targeting practice change among HCPs - we have identified several areas that could help advance the field. These include optimizing the content and delivery of adherence interventions, understanding how to implement effective strategies, and reaffirming the need for health system-level solutions.